TNF and metabolic dysfunction-associated steatotic liver disease: Pathologically, Firmicutes could induce obesity and hepatic steatosis and promoted the elevation of TNF-α mRNA levels, suggesting that Firmicutes might be involved in the pathogenesis of the nonalcoholic fatty liver disease (NAFLD) [33–35].